Login

Ben McMillan, founder and CIO of IDX Digital Assets, discusses the key factors driving the crypto market in an interview with CNBC Crypto World. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Spark Capital invests in products we love by creators we admire across all sectors|Todd Dagres,Founder and General Partner,Spark Capital
00:10:00
BioLargo CEO Dennis Calvert Speaks on Sustainable Innovations at Norwegian Embassy Summit | Dennis Calvert , CEO, BioLargo Inc.
00:10:00
Navigating Inflation: Insights for Your Investments
00:10:00
Exploring Global Ventures: An Interview with Marco Soriano, CEO of Soriano Group
00:10:00
Tim Chen, CEO of NerdWallet, appears on 'Closing Bell Overtime' to discuss quarterly results, the lending environment, and more.|Tim Chen is the founder and CEO of NerdWallet.
00:10:00
Tom Wolfe on 'Back to Blood' and Modern Identity
00:10:00
Clean Harbors CEO: Environmental business is 'really strong' amid increasing demand for environmental services and solutions.
00:10:00
help entrepreneurs navigate the Supercritical phase|Renata Quintini,Co-Founder and Managing Director,Renegade Partners
00:10:00
The diagnostic tests will differentiate between squamous and non-squamous non-small cell lung cancer|Robert Wassman, MD,Rosetta Genomics Ltd
00:10:00
Navigating Capital Flows and Market Transformations: Insights from Leading Experts | David Hunt, CEO, PGIM, the Global Investment Management Businesses of Prudential Financial, Inc.
00:10:00
Balancing Growth and Capital Preservation: Mark Burgess on the Bennelong Kardinia Absolute Return Fund | Mark Burgess - Portfolio Manager, Kardinia Capital
00:10:00
Leaders Discuss Solutions for the New Decade | Keiichi Yoshii, CEO , Daiwa house industry co.

© 2017 - Neuhu+